Bb Biotech as of March 31, 2018
Portfolio Holdings for Bb Biotech
Bb Biotech holds 30 positions in its portfolio as reported in the March 2018 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Ionis Pharmaceuticals (IONS) | 10.4 | $375M | 8.5M | 44.08 | |
Incyte Corporation (INCY) | 8.5 | $308M | 3.7M | 83.33 | |
Celgene Corporation | 8.2 | $297M | 3.3M | 89.21 | |
Neurocrine Biosciences (NBIX) | 7.8 | $282M | 3.4M | 82.93 | |
Vertex Pharmaceuticals Incorporated (VRTX) | 6.7 | $241M | 1.5M | 162.98 | |
Radius Health | 5.8 | $210M | 5.9M | 35.94 | |
Agios Pharmaceuticals (AGIO) | 5.7 | $207M | 2.5M | 81.78 | |
Gilead Sciences (GILD) | 5.6 | $202M | 2.7M | 75.39 | |
Esperion Therapeutics (ESPR) | 4.8 | $175M | 2.4M | 72.33 | |
Halozyme Therapeutics (HALO) | 4.6 | $167M | 8.5M | 19.59 | |
Sage Therapeutics (SAGE) | 4.5 | $162M | 1.0M | 161.07 | |
Alexion Pharmaceuticals | 4.3 | $155M | 1.4M | 111.46 | |
Alnylam Pharmaceuticals (ALNY) | 3.3 | $121M | 1.0M | 119.10 | |
Regeneron Pharmaceuticals (REGN) | 2.7 | $96M | 280k | 344.36 | |
Tesaro | 2.6 | $93M | 1.6M | 57.14 | |
Myovant Sciences | 2.1 | $75M | 3.5M | 21.27 | |
Macrogenics (MGNX) | 1.8 | $65M | 2.6M | 25.16 | |
Akcea Therapeutics Inc equities | 1.7 | $61M | 2.4M | 25.61 | |
Avexis | 1.4 | $50M | 403k | 123.58 | |
Intra Cellular Therapies (ITCI) | 1.3 | $46M | 2.2M | 21.05 | |
Voyager Therapeutics (VYGR) | 1.0 | $37M | 2.0M | 18.79 | |
Wave Life Sciences (WVE) | 1.0 | $36M | 896k | 40.10 | |
Intercept Pharmaceuticals In | 0.9 | $34M | 546k | 61.52 | |
Argenx Se (ARGX) | 0.9 | $32M | 397k | 80.44 | |
Alder Biopharmaceuticals | 0.8 | $29M | 2.3M | 12.70 | |
Novavax | 0.5 | $18M | 8.3M | 2.10 | |
Five Prime Therapeutics | 0.5 | $17M | 978k | 17.18 | |
Prothena (PRTA) | 0.4 | $15M | 400k | 36.71 | |
Cidara Therapeutics Inc Common Stock Usd 0.0001 | 0.2 | $9.2M | 2.3M | 4.00 | |
Achillion Pharmaceuticals | 0.1 | $4.7M | 1.3M | 3.71 |